NPPA fixes price of Cipla Synchrobreathe inhaler device; Details Medical Dialogues Bureau22 Dec 2019 2:26 PM ISTNew Delhi: Price of Synchrobreathe inhaler device manufactured by pharma giant Cipla has been set at Rs 67.20 after the National Pharmaceutical...
Cipla launches respiratory inhalation therapy product Niveoli in India Farhat Nasim12 April 2019 11:41 AM ISTNew Delhi: Drug major Cipla Friday announced the launch of its proprietary respiratory inhalation therapy product 'Niveoli' in India. Niveoli is used...
AstraZeneca's three in one inhaler helps COPD patients in trial Medical Dialogues Bureau30 Jan 2018 9:45 AM ISTAstraZeneca said an inhaler for chronic obstructive pulmonary disease delivered improved lung function in a late-stage trial that could challenge...
FDA acts to encourage generic competition for complex drugs Ruby Khatun Khatun4 Oct 2017 10:46 AM ISTTRENTON, N.J.: The U.S. Food and Drug Administration (FDA) is opening a new front in its efforts to reduce high drug prices by encouraging the...
USFDA approves GSK three-in-one drug inhaler for COPD Ruby Khatun Khatun19 Sept 2017 9:57 AM ISTGlaxoSmithKline Plc (GSK) and Innoviva Inc said on Monday the U.S. Food and Drug Administration has approved their triple drug inhaler for the...
Propeller Health and GSK expands digital health collaboration for Asthma and COPD Ruby Khatun Khatun28 Aug 2017 9:15 AM ISTMADISON: Propeller Health, a leading digital solution for respiratory medicine, today announced the expansion of its 2015 collaboration with GSK,...
